These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22121251)

  • 41. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular pseudoparkinsonism.
    Chang CM; Yu YL; Ng HK; Leung SY; Fong KY
    Acta Neurol Scand; 1992 Dec; 86(6):588-92. PubMed ID: 1481645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report.
    de Bruin VM; Lees AJ; Daniel SE
    Mov Disord; 1992 Oct; 7(4):355-8. PubMed ID: 1484531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions.
    van Zagten M; Lodder J; Kessels F
    Mov Disord; 1998 Jan; 13(1):89-95. PubMed ID: 9452332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benign tremulous parkinsonism.
    Josephs KA; Matsumoto JY; Ahlskog JE
    Arch Neurol; 2006 Mar; 63(3):354-7. PubMed ID: 16533962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular Parkinsonism: a case report and review of the literature.
    Peters S; Eising EG; Przuntek H; Müller T
    J Clin Neurosci; 2001 May; 8(3):268-71. PubMed ID: 11386806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Brain tumor and parkinsonism].
    Kondo T
    Nihon Rinsho; 1997 Jan; 55(1):118-22. PubMed ID: 9014433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.
    Zijlmans JC; Daniel SE; Hughes AJ; Révész T; Lees AJ
    Mov Disord; 2004 Jun; 19(6):630-40. PubMed ID: 15197700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parkinson's disease: making the diagnosis, selecting drug therapies.
    Scharre DW; Mahler ME
    Geriatrics; 1994 Oct; 49(10):14-6, 20-3. PubMed ID: 7926845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative gait analysis in patients with vascular parkinsonism.
    Zijlmans JC; Poels PJ; Duysens J; van der Straaten J; Thien T; van't Hof MA; Thijssen HO; Horstink MW
    Mov Disord; 1996 Sep; 11(5):501-8. PubMed ID: 8866491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular parkinsonism.
    Sibon I; Fenelon G; Quinn NP; Tison F
    J Neurol; 2004 May; 251(5):513-24. PubMed ID: 15164182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
    Poewe W
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The L-dopa response in vascular parkinsonism.
    Zijlmans JC; Katzenschlager R; Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):545-7. PubMed ID: 15026493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease.
    Louis ED; Goldman JE; Powers JM; Fahn S
    Mov Disord; 1995 Mar; 10(2):188-94. PubMed ID: 7753061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.
    Schrag A; Ben-Shlomo Y; Brown R; Marsden CD; Quinn N
    Mov Disord; 1998 Nov; 13(6):885-94. PubMed ID: 9827611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
    Constantinescu R; Richard I; Kurlan R
    Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative assessment of clinical features and imaging findings for patients with vascular parkinsonism and idiopathic Parkinson's disease].
    Zhao DQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):868-70. PubMed ID: 16027088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
    Devos D;
    Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.